Completed NA INTERVENTIONAL 2-arm NCT01532609

Methadone Maintenance and HIV Prevention: A Window of Opportunity in China (MMT1)

Methadone Maintenance and HIV Prevention: A Window of Opportunity in China Version

Sponsor: Centers for Disease Control and Prevention, China

Conditions Capacity Building Drug Use HIV/AIDS

Interventions MMT CARE

Updated 6 times since 2017 Last updated: Sep 28, 2023 Started: Mar 31, 2009 Primary completion: Dec 31, 2010 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01532609, this NA trial focuses on Capacity Building and Drug Use and remains completed. Sponsored by Centers for Disease Control and Prevention, China, it has been updated 6 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Nov 2023 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention, China
University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chengdu, China